Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.32 Vs. IBES Estimate USD -0.32
08/05/2024 21:05
May 08 (Reuters) - Sana Biotechnology Q1 operating expenses USD 110.724 million. * Q1 net income USD -107.475 million * Q1 adjusted net income USD -69.468 million vs. IBES estimate USD -69.6 million * Q1 EPS USD -0.49
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17